GTC Biotherapeutics (fka GTCB)

[read_this_n0w]

How much would a potential additional deal need to bring in with upfront cash for GTCB to get the company past atryn fda ruling,?

(at which point further financing would be less hurtfull for current holders and further deals more likely once first fda approval for the transgenic technology is there, providing a positive scenario that is)

and what other news items could the company use to support interest in the stock?

opinions welcome based on current cash and cash burn numbers

i fully expect priority review, not sure what timeframe in Q1 '09 is the most likely for a fda ruling

FDA approval still good for nice jump and usually overenthusiastic jump regardless of market potential, especially since it would be validation of the model used